Follow CGSP on Social Media

Listen to the CGSP Podcast

COVID Wave Drives Chinese Consumers to Indian Generics

by Cobus van Staden
TRANSLATION: Thousands of dollars for Indian-made generic COVID medications sold out? Be careful!

As the BF7 Omicron variant pushes China’s public health care system to its limits, the country is running out of antiviral medications like Pfizer’s Paxlovid.

These shortages seem to be driving people to the black market, with consumers competing to order generic versions of the drug, many from India, that haven’t been approved in China.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

OR

Already a subscriber? Log in Click Here to Learn More

You Might Like

With the COVID Crisis Exploding in India, More Countries Turn to China to Fill the Vaccine Void

The vaccine distribution dynamic is rapidly changing in response to the unfolding calamity in India, where the country’s healthcare system has collapsed due to an explosion of infections across the country. ...

China’s Global Vaccine Distribution Drive Appears to Have Come to a Halt… At Least For Now

China’s once frenetic global vaccine distribution drive appears to have come to a grinding halt, at least temporarily, amid a push to gets jabs into the arms of its own people (photo). 

Global Times: Africa and Latin America Will Prefer a Chinese-Made COVID-19 Vaccine

Chinese propaganda outlets are moving to frame the narrative that Chinese-made COVID-19 vaccines are better suited for developing countries compared to those made by U.S. and European organizations.  “African and some Latin American ...

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.

Subscribe